We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
-6.53%
1 Year Est. Return
+16.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$509M
AUM Growth
+$162M
Cap. Flow
-$12.1M
Cap. Flow %
-2.38%
Top 10 Hldgs %
56.64%
Holding
263
New
5
Increased
9
Reduced
87
Closed
77

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.44M
2
INTU icon
Intuit
INTU
+$6.36M
3
APD icon
Air Products & Chemicals
APD
+$5.82M
4
TMUS icon
T-Mobile US
TMUS
+$5.63M
5
XOM icon
ExxonMobil
XOM
+$4.32M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$6.36M
2
BAC icon
Bank of America
BAC
+$5.97M
3
ASML icon
ASML
ASML
+$2.83M
4
PFE icon
Pfizer
PFE
+$2.15M
5
NVDA icon
NVIDIA
NVDA
+$1.82M

Sector Composition

Rank Sector Weight
1 Technology 36.62%
2 Materials 11.95%
3 Healthcare 11.51%
4 Miscellaneous 8.4%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
1
Adobe
ADBE
$116B
$63.8M 12.54%
23,185
+169
+0.7% +$63.9K
APD icon
2
Air Products & Chemicals
APD
$68.6B
$54.7M 10.76%
+23,511
New +$5.82M
ACN icon
3
Accenture
ACN
$116B
$51.9M 10.19%
20,153
-767
-4% -$222K
MSFT icon
4
Microsoft
MSFT
$3.81T
$19.7M 3.88%
84,652
-2,570
-3% -$679K
AAPL icon
5
Apple
AAPL
$4.67T
$16M 3.15%
116,116
-902
-0.8% -$142K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.24T
$12.3M 2.42%
128,614
-3,186
-2% -$353K
CVS icon
7
CVS Health
CVS
$119B
$11.5M 2.26%
120,716
-2,649
-2% -$262K
NEE icon
8
NextEra Energy
NEE
$171B
$10.6M 2.08%
135,078
-17,897
-12% -$1.52M
PANW icon
9
Palo Alto Networks
PANW
$303B
$10.4M 2.05%
127,226
-604
-0.5% -$52.3K
AMZN icon
10
Amazon
AMZN
$2.87T
$10.1M 1.98%
89,307
-748
-0.8% -$94.5K
TMO icon
11
Thermo Fisher Scientific
TMO
$230B
$10M 1.97%
19,712
-1,171
-6% -$655K
QCOM icon
12
Qualcomm
QCOM
$175B
$9.69M 1.9%
85,759
-2,349
-3% -$323K
COST icon
13
Costco
COST
$419B
$9.23M 1.82%
19,554
+76
+0.4% +$39.5K
JNJ icon
14
Johnson & Johnson
JNJ
$646B
$8.8M 1.73%
53,865
-2,623
-5% -$444K
UNH icon
15
UnitedHealth
UNH
$353B
$8.31M 1.63%
16,456
-794
-5% -$418K
HD icon
16
Home Depot
HD
$329B
$7.84M 1.54%
28,418
+157
+0.6% +$46.3K
XOM icon
17
ExxonMobil
XOM
$644B
$7.74M 1.52%
88,599
+47,339
+115% +$4.32M
J icon
18
Jacobs Solutions
J
$17.8B
$7.65M 1.5%
85,235
-1,847
-2% -$191K
PFE icon
19
Pfizer
PFE
$159B
$7.58M 1.49%
173,348
-44,258
-20% -$2.15M
SLB icon
20
SLB Ltd
SLB
$85.1B
$7.33M 1.44%
204,206
-1,494
-0.7% -$54.2K
LLY icon
21
Eli Lilly
LLY
$1.05T
$7.09M 1.39%
21,937
+20,313
+1,251% +$6.44M
BR icon
22
Broadridge
BR
$20.9B
$6.86M 1.35%
47,542
-692
-1% -$112K
LHX icon
23
L3Harris
LHX
$48.9B
$6.71M 1.32%
32,278
-822
-2% -$190K
SPGI icon
24
S&P Global
SPGI
$131B
$6.68M 1.31%
21,882
-269
-1% -$96.2K
CB icon
25
Chubb
CB
$131B
$6.65M 1.31%
36,581
-1,167
-3% -$222K

Similar funds

Cyrus J. Lawrence's Q3 2022 Portfolio in Review

As of Q3 2022, Cyrus J. Lawrence held 263 positions worth $509M, up 47% from $347M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Cyrus J. Lawrence's Q3 2022 filing shows 5 new, 9 increased, 87 reduced and 77 closed positions. Its largest new stake was Intuit: 14,715 shares worth $5.7M. The largest sale was Cisco, an estimated $6.36M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 27% a quarter earlier, followed by Materials and Healthcare.

  • Cyrus J. Lawrence's largest Q3 2022 buy was Intuit: 14,715 shares worth $5.7M.
  • Cyrus J. Lawrence added most to Eli Lilly in Q3 2022, an estimated $6.44M increase.
  • Cyrus J. Lawrence's biggest Q3 2022 reduction was Cisco, cutting an estimated $6.36M.
  • Cyrus J. Lawrence fully exited Charles Schwab 5.95% Series D Preferred Stock in Q3 2022, selling an estimated $877K.
  • Cyrus J. Lawrence's ten largest holdings make up 57% of its $509M portfolio in Q3 2022.
  • Cyrus J. Lawrence opened 5 new positions and closed 77 in Q3 2022.
  • Cyrus J. Lawrence's portfolio value rose 47% quarter-over-quarter to $509M.

Based on Cyrus J. Lawrence's 13F filing for Q3 2022, filed 9 Nov 2022.